Early Neurological Deterioration in Stroke Patients

Primary Mechanisms of Early Deterioration

Approximately 25% of stroke patients deteriorate within the first 24-48 hours after initial presentation, due to mechanisms including evolving ischemia, hemorrhagic transformation, cerebral edema, and metabolic derangements 1
Secondary neuronal injury results from free radical generation and inflammatory processes involving activated leukocytes in the ischemic zone 1

Hyperglycemia is particularly detrimental and independently predicts infarct expansion and poor neurological outcomes, with persistent hyperglycemia (blood glucose >200 mg/dL) during the first 24 hours predicting expansion of stroke volume and neurological worsening 2
Hyperglycemia increases tissue acidosis through anaerobic glycolysis, lactic acidosis, and free radical production, disrupts the blood-brain barrier, promotes cerebral edema development, and increases hemorrhagic transformation risk 2
Hypoglycemia can produce neurological signs mimicking stroke progression and causes direct brain injury 2

Ischemic strokes can undergo hemorrhagic transformation, particularly in patients with elevated blood glucose levels or those receiving thrombolytic therapy, with a symptomatic hemorrhage rate of approximately 7% in thrombolysis-treated patients versus 1.1% in untreated patients 2, 3

Patients with TIA or minor stroke face a 10% risk of recurrent stroke within the first week, with 3.1% risk at 2 days and 5.2% at 7 days, and the highest risk patients are those presenting within 48 hours with transient, fluctuating, or persistent unilateral weakness or speech disturbance 4
Up to 60% of stroke survivors develop post-stroke cognitive impairment (PSCI) in the first year, with 59% at 3 months even after mild stroke, and risk factors for progressive decline include stroke recurrence, older age, baseline cognitive impairment, hypertension, diabetes, and brain atrophy 5, 6

Excessively high blood pressures pose safety risks but must be managed carefully to avoid compromising penumbral perfusion, and overly aggressive blood pressure lowering can worsen outcomes by reducing cerebral perfusion 1, 2
Treatment should be initiated when blood glucose exceeds 200 mg/dL, targeting levels between 80-140 mg/dL with frequent monitoring, to prevent hyperglycemia-related complications 2
Earlier thrombolytic treatment (within 90 minutes) yields better outcomes than later treatment (90-180 minutes), with odds ratios of 2.11 versus 1.69 for favorable outcomes 3